Epidemiology of Drug Abuse

The summary for the Epidemiology of Drug Abuse grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.

Epidemiology of Drug Abuse: This program announcement (PA) replaces PA-99-002, Epidemiologic Research on Drug Abuse, published in the NIH Guide, October 2, 1998; PA-99-113, Drug Use and Related Adverse Behavioral and Social Consequences, published in the NIH Guide, June 18, 1999; and PAR 99-168, Research on the Origins and Pathways to Drug Abuse. This new PA encourages a broad range of epidemiologic research on drug use, abuse, and dependence. It highlights new areas for research that emphasize the vital public health role of epidemiologic research in drug abuse.The major goal of this PA is to stimulate innovative investigations that enhance our understanding of: (1) drug use patterns and trends within and across populations; (2) interplay of social interactions, social environment, structural context with individual behavioral characteristics and genetic vulnerability; (3) the phenotypic heterogeneity of drug abuse; (4) causal mechanisms leading to onset, maintenance, and remittance of drug abuse, as well as protective mechanisms that reduce the risk of drug abuse; and (5) drug abuse over the life course, including developmental processes that influence drug use trajectories and behavioral, health, and social consequences of drug abuse. In addition, research is encouraged to develop methodologies to improve the accuracy, efficiency, scope, timeliness, and analytic yield of drug abuse epidemiologic data. Because of the breadth of epidemiology research, applications are anticipated to reflect diverse and multidisciplinary putative approaches and multiple levels of causation. To take advantage of the strength of specific research fields in an efficient manner, and to maximize the generalizability of findings, researchers are encouraged to develop and/or incorporate innovations in epidemiologic study design. Such designs may include nesting of biological and/or basic research, contextual analysis, and contemporary longitudinal analyses.